Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

LPTX Leap Therapeutics Inc

0,6789

-1,57 (-69,83%)

Zuletzt aktualisiert: 15:56:39

Verzögert um 15 Minuten

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Leap Therapeutics (NASDAQ:LPTX)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Leap Therapeutics Charts.

Leap Therapeutics (NASDAQ:LPTX)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Leap Therapeutics Charts.

News Leap Therapeutics Inc

Form 8-K - Current report
Dienstag 28 Januar 2025 (2 Stunden vor) • Edgar (US Regulatory)

Leap Therapeutics Reports Initial Clinical Data from Part B of the DeFianCe Study and Part C of the DisTinGuish Study
Dienstag 28 Januar 2025 (3 Stunden vor) • PR Newswire (US)

Leap Therapeutics to Participate at the 43rd Annual J.P. Morgan Healthcare Conference
Montag 6 Januar 2025 (3 Wochen vor) • PR Newswire (US)

Leap Therapeutics to Participate at Piper Sandler 36th Annual Healthcare Conference
Dienstag 26 November 2024 (2 Monate vor) • PR Newswire (US)

Form 8-K - Current report
Mittwoch 13 November 2024 (3 Monate vor) • Edgar (US Regulatory)

Leap Therapeutics Reports Third Quarter 2024 Financial Results
Mittwoch 13 November 2024 (3 Monate vor) • PR Newswire (US)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mittwoch 13 November 2024 (3 Monate vor) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Mittwoch 6 November 2024 (3 Monate vor) • Edgar (US Regulatory)

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Donnerstag 31 Oktober 2024 (3 Monate vor) • Edgar (US Regulatory)

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Donnerstag 31 Oktober 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 4 Oktober 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 4 Oktober 2024 (4 Monate vor) • Edgar (US Regulatory)

Weitere Leap Therapeutics Inc News-Artikel

Deutsche Lufthansa

JP Morgan Chase

Invesco QQQ Trust Series 1

BNP Paribas (QX)

Euro vs Sterling

Financial Select Sector

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen